Search for: "Par Pharmaceutical"
Results 141 - 160
of 303
Sorted by Relevance
|
Sort by Date
12 Oct 2009, 12:38 pm
Citigroup Global Market, Inc. has filed a motion to dismiss an action against it by KV Pharmaceuticals Co. arising out of sales of auction rate securities, according to an August 25 article in Law360 by Christine Caufield entitled "Citigroup Argues KV Pharma Knew ARS Risks. [read post]
21 May 2013, 2:26 pm
., a subsidiary of the Indian generic pharmaceutical manufacturer Ranbaxy Laboratories Limited. [read post]
28 Jun 2010, 8:00 am
The court’s decision dramatically expands the number of investor suits against pharmaceutical companies that state a claim and substantially increases the pressure on companies to settle meritless claims. [read post]
21 Jan 2008, 3:22 am
Third Company Adopts â [read post]
25 Jun 2013, 6:52 am
Soon after, two other companies, Actavis and Paddock (the latter in agreement with a third company, Par Pharmaceutical) had filed Abbreviated New Drug Applications for generic drugs modeled after AndroGel, declaring that Solvay’s patent 6,503,894 was invalid, under paragraph 4 of the Hatch-Waxman Act. [read post]
25 Jun 2013, 9:51 am
Par Pharmaceutical backed Paddock by agreeing to share the patent litigation costs if it obtained approval for its generic product. [read post]
28 Mar 2011, 2:42 pm
Karst – Late last week, Par Pharmaceutical, Inc. [read post]
20 Mar 2022, 4:42 pm
I, 2e éd. 2016, no 1884 ; par analogie : arrêt du TAF B-6637/2014 du 10 octobre 2016 consid. 3.1.2 "sensationail [fig.] [read post]
4 Jan 2022, 10:33 am
A Pennsylvania federal judge ordered California to pay nearly $80,000 in legal fees to Par Pharmaceutical Inc for failing to comply with discovery obligations in multidistrict litigation alleging a broad price-fixing conspiracy for generic drugs. [read post]
4 Jan 2022, 10:33 am
A Pennsylvania federal judge ordered California to pay nearly $80,000 in legal fees to Par Pharmaceutical Inc for failing to comply with discovery obligations in multidistrict litigation alleging a broad price-fixing conspiracy for generic drugs. [read post]
9 Mar 2007, 2:07 am
"You're not going to implement technology for the sake of technology," says Gabrielle Wolfson, chief information officer of Par Pharmaceutical. [read post]
12 Feb 2008, 11:34 am
Verizon, Par Pharmaceutical and Aflac became the first US companies over the last year to adopt policies requiring an advisory vote of shareholders on company executive compensation practices. [read post]
13 Apr 2009, 5:00 am
Reddy’s and it’s negotiations with health insurers to sell its Simvastatin (Zocor) on par with the generic. [read post]
9 Mar 2009, 7:00 am
Skylight Studios275 Hudson Street, NYC7 pm - 10 pmPURCHASE TICKETS Participating chefs Anne BurrellThe Food Network Anita LoAnnisa Pichet OngP*ONG Suvir SaranDevi Lawrence Benenson Fiona and Stanley Druckenmiller Leslie Fay Pomerantz Anita Jaffe Bloomberg Davis Polk & Wardwell Jeffrey FashionCares 2009 May and Samuel Rudin Family Foundation Sonnenschein Nath &… [read post]
13 Jul 2018, 5:48 pm
” Par Pharm., 773F.3d at 1195 (quoting In re Oelrich, 666 F.2d 578, 581(CCPA 1981)). [read post]
16 Nov 2011, 10:00 am
Reddy's Laboratories Ltd., and Par Pharmaceuticals Inc. [read post]
2 Jun 2022, 7:01 am
The boss said Owens’ performance was sub-par. [read post]
21 Jan 2007, 8:53 pm
(a Par Pharmaceutical subsidiary), No. 02-CV-5707-JCL-MF (D. [read post]
18 Aug 2010, 12:19 am
Par Pharmaceutical, Inc. et al. [read post]
11 Apr 2019, 4:00 am
This paper focuses specifically on developing countries and portrays some practical cases of technology transactions in the pharmaceutical industry (ELEA in Argentina; Beximco Pharmaceuticals Ltd in Bangladesh; Technoquimicas in Colombia; SEAA in Ethiopia; and Quality Chemicals in Uganda) to analyse the lessons and limitations of the licensing approach. [read post]
